The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
Previous Story
OPEC Plus Signals Cautious Approach to Oil Production
Next Story
Martha Stewart Transformed the Dinner Party. Was That a Good Thing?
